<DOC>
	<DOCNO>NCT01882946</DOCNO>
	<brief_summary>The study comprise Phase I component optimal dose DCVax-Direct treatment solid tissue tumor identify , follow Phase II component determine injection DCVax-Direct select solid tissue tumor ability reduce tumor growth .</brief_summary>
	<brief_title>Safety Efficacy Study DCVax-Direct Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Inclusion Criteria ( summary ) : Age 18 75 year ( inclusive ) screening . Karnofsky performance status ( KPS ) 70 high Eastern Cooperative Oncology Group ( ECOG ) 01 screen . Subjects histological cytopathological confirm diagnosis locally advance metastatic solid tumor malignancy primary treatment longer effective offer curative lifeprolonging potential per clinician judgment , understand DCVaxDirect intend treatment last resort . Not eligible complete resection due either tumor location , physician 's assessment subject 's choice . Must complete least one recent treatment regimen metastatic advance set disease currently treatment reduce tumor burden . Any steroid therapy &gt; 2 mg dexamethasone equivalent dose stop taper 2 week prior leukapheresis . At least one measurable tumor mass , i.e . lesion accurately measure CT/MRI least one dimension long diameter ≥ 1 cm , accessible injection either without image ( CT/ultrasound ) guidance . Adequate hematological , hepatic , renal function , Adequate blood coagulation parameter Life expectation &gt; 3 month . Exclusion Criteria ( Summary ) : Positive HIV1 , HIV2 , Human Tlymphotropic virus ( HTLVI/II ) test . History current prior ( within last two year ) active clinically significant malignancy tumor type DCVaxDirect treatment consider , except primary tumor case metastases adequately treat basal cell squamous cell skin cancer situ cervical cancer . Heavily pretreated ( HP ) subject eligible study , unless treatment occur 1 year past . Presence brain metastasis , unless treat surgically and/or irradiate clinically stable steroid low dose ( &lt; 2 mg per day ) steroids ≥ 14 day , presence leptomeningeal disease . History immunodeficiency unresolved autoimmune disease . Requirement ongoing immunosuppressant . Prior active immunotherapy cancer within past 2 year . Ongoing medical need continuous anticoagulation antiplatelet medication . Known genetic cancersusceptibility syndrome . Acute active uncontrolled infection Ongoing fever ≥ 101.5 degree F/38.6 degree C screening . Unstable severe intercurrent medical condition unstable angina , uncontrolled arrhythmia , Crohn 's Disease , ulcerative colitis etc . Females childbearing potential pregnant lactate use adequate contraception ( surgical , hormonal double barrier , i.e . condom diaphragm ) . Allergy anaphylaxis reagent use study . Inability obtain informed consent psychiatric complicate medical problem . Inability unwillingness return require visit followup exam .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>